IMCD Group NV

IMCD Group is a specialty chemicals group based in the Netherlands. Co. is engaged in the sale, marketing and distribution of specialty chemicals and food ingredients globally. Co.'s business groups are Detergents, Pharma, Personal Care, Coatings, Food & Nutrition, Lubricants, Synthesis, Plastics and others. Co.'s product offering includes additives, antioxidants, extracts, preservatives, acids, lubricants, oils, softeners, wax, components for oral, topical and vaccine drug formulations, fragrances, pigments, solvents, resins, flavors, herbs and spices, surface active agents, and fillers, among others. Co. maintains offices and warehouses in Europe, Asia Pacific, Africa, the USA and Brazil.
  • TickerA116P8
  • ISINNL0010801007
  • ExchangeStuttgart Stock Exchange
  • SectorChemicals
  • CountryGermany

Analysts

ING
ING Helpdesk

Benelux Morning Notes

ING Benelux Conference London - highlights. Other news: Belgian telecoms: Major court victory for the BIPT. Euronext: August activity levels bounce back. EVS: New CEO, surprise departure of Chairman. Fagron: Waterland/Baltisse divest another 7.25%

ING
Quirijn Mulder

IMCD/Wait and see/HOLD (previously Buy)

IMCD came with unpleasant 1H19/2Q19 figures, which reflected macro challenges and risk in IMCD's growth model. As we believe the macro uncertainty will not disappear overnight, we believe the upside is limited. Therefore we change our recommendation from Buy to HOLD and reduce our TP from €75 to €65.

ING
Research Department

Benelux Morning Notes

comments

IMCD GROUP sees a downgrade to Slightly Negative on account of less fundamental stars

The independent financial analyst theScreener just lowered the general evaluation of IMCD GROUP (NL), active in the Specialty Chemicals industry. As regards its fundamental valuation, the title now shows 1 out of 4 stars while market behaviour can be considered moderately risky. theScreener believes that the title remains under pressure due to the loss of a star(s) and downgrades its general evaluation to Slightly Negative. As of the analysis date August 6, 2019, the closing price was EUR 76.25 and its target price was estimated at EUR 69.80.

ING
ING Helpdesk

Benelux Morning Notes

ING Benelux Conference London - highlights. Other news: Belgian telecoms: Major court victory for the BIPT. Euronext: August activity levels bounce back. EVS: New CEO, surprise departure of Chairman. Fagron: Waterland/Baltisse divest another 7.25%

ING
Quirijn Mulder

IMCD/Wait and see/HOLD (previously Buy)

IMCD came with unpleasant 1H19/2Q19 figures, which reflected macro challenges and risk in IMCD's growth model. As we believe the macro uncertainty will not disappear overnight, we believe the upside is limited. Therefore we change our recommendation from Buy to HOLD and reduce our TP from €75 to €65.

ING
Research Department

Benelux Morning Notes

comments

ING
Research Department

Benelux Morning Notes

Ahold Delhaize: In-line results, showing solid US performance and weaker Europe. Aperam: An ‘unsurprising' 8% 1Q19 EBITDA miss. Barco: Preview of bi-annual CMD on Thursday 9 May. Bekaert: 1Q19 sales slightly beat, increasing net debt key focus point Euronext: Tough month for Euronext FX Home Invest Belgium: Accounting change lowers debt ratio IBA: Guidance confirmed, strong ‘Other accelerators', no news on Dosimetry or PPI IMCD: Again a beat KBC: Czech earnings face new tax burden (impact of up to 5% of KBC's net profit) Kinepolis: Unsupportive start to the year, offset by “Avengers” in Q...

ING
Research Department

Benelux Morning Notes

BAM: Preview - Update on sea lock is key. IMCD: Likely to again see double digit EBITA growth. Staffing sector: US April Temp data trend stable; US job report positive

1 director sold

A director at IMCD NV sold 500,000 shares at 64.000EUR and the significance rating of the trade was 83/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board membe...

IMCD GROUP sees a downgrade to Slightly Negative on account of less fundamental stars

The independent financial analyst theScreener just lowered the general evaluation of IMCD GROUP (NL), active in the Specialty Chemicals industry. As regards its fundamental valuation, the title now shows 1 out of 4 stars while market behaviour can be considered moderately risky. theScreener believes that the title remains under pressure due to the loss of a star(s) and downgrades its general evaluation to Slightly Negative. As of the analysis date August 6, 2019, the closing price was EUR 76.25 and its target price was estimated at EUR 69.80.

Ford Equity International Rating and Forecast Report

Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week...

Expert Corporate Governance Service (ECGS)

IMCD - AGM 08 May 2019

In general, IMCD is in compliance with the Dutch regulations relating to the organisation and procedures of the Annual General Meeting. Under ITEM 5b, the executive board, subject to the approval of the supervisory board, seeks authorisation to be the designated body entitled to restrict and/or exclude pre-emptive rights upon issuing ordinary shares. In aggregate, the authorisation requested is limited to 20% of the Company's share capital and thereby exceeds ECGS' guidelines. Accordingly, ECGS recommends to vote OPPOSE. There are no further peculiarities.

Dave Nicoski ...
  • Ross LaDuke

Vermilion Int'l Compass: Global Equity Strategy

Bottoms-up view on developed int'l, part two Big Picture: Our outlook remains neutral on the MSCI ACWI ex-U.S. index (when priced in local currency) while horizontal consolidation continues. On the other hand, we are negative on broad global ex-U.S. markets when priced in USD... see charts below. In today's report we take a bottoms-up approach to developed ex-U.S. equities, highlighting stocks that present attractive buy opportunities at current levels. Specifically we present actionable stocks within the Communications, Health Care, Manufacturing, Materials, Technology, Transportation, and U...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch